| Item | Value |
|---|---|
| DrugBank ID | DB12498 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 11 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma | TxGNN Knowledge Graph |
| 2 | primary cutaneous peripheral T-cell lymphoma not otherwise specified | TxGNN Knowledge Graph |
| 3 | mycosis fungoides and variants | TxGNN Knowledge Graph |
| 4 | mature T-cell and NK-cell non-Hodgkin lymphoma | TxGNN Knowledge Graph |
| 5 | primary cutaneous gamma/delta-positive T-cell lymphoma | TxGNN Knowledge Graph |
| 6 | primary cutaneous T-cell lymphoma | TxGNN Knowledge Graph |
| 7 | primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma | TxGNN Knowledge Graph |
| 8 | folliculotropic mycosis fungoides | TxGNN Knowledge Graph |
| 9 | peripheral T-cell lymphoma, not otherwise specified | TxGNN Knowledge Graph |
| 10 | localized pagetoid reticulosis | TxGNN Knowledge Graph |
| 11 | granulomatous slack skin disease | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.